Ashwagandha Advantage is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

The Global Ashwagandha Market - report

The Global Ashwagandha Market - report

In a recent survey, one-third of Americans said they would consider buying natural products that address stress. With ashwagandha's long history of use as a stress reliever—in addition to supporting immunity, sexual function and more—the versatile adaptogen holds increasing global appeal. Although European Union (EU) member states take different regulatory approaches to food supplements, the botanical is starting to find opportunity abroad as countries such as Belgium and Spain navigate the regulatory waters.

Takeaways for Your Business

• Cross-channel growth of U.S. products containing ashwagandha rose 40% from mid-2016 to mid-2017.
• In the EU, meeting safety and legal requirements is key to using ashwagandha in food supplements.
• The “mutual recognition” principle allows a product sold in one EU country to be sold in another.

Register to download this resource

Registering as a member of Ashwagandha Advantage will give you free access to premium content including digital magazines, webinars, whitepapers and more.